Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Blocking the CXCL12–CXCR4 axis may help treat hair loss in alopecia.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

JAK inhibitors help with skin conditions but need more research on dosing and safety.